Advertisement

Muscle and Myofascial Pain

  • Rene Przkora
  • Pavel Balduyeu
  • Andrea Trescot
Chapter

Abstract

Myofascial pain syndrome (MPS) is a common pain condition and one of a spectrum of soft tissue pain syndromes (Mense and Gerwin, Muscle pain: understanding the mechanisms. Springer, New York, 2010). Patients can demonstrate pain in one or more body regions associated with referred pain to a site not associated with the pain source. Taut muscle bands and especially myofascial trigger points (MTrPs) are the key components of the diagnosis, which is mostly clinical. MPS can be acute or chronic and can be associated with additional pain syndromes such as cervical facet joint syndrome and headaches. An excessive release of acetylcholine (ACh) plays a role in the pathophysiology, triggering more muscle spasms and the release of biologically active molecules, leading to peripheral and central sensitization. Therapy is usually multimodal with physical modalities including stretching exercises and trigger point injection therapy.

Keywords

Myofascial pain syndrome MPS Fibromyalgia Trigger point Taut bands Trigger point injection Myofascial release Myalgia 

References

  1. 1.
    Mense S, Gerwin RD. Muscle pain: understanding the mechanisms. New York: Springer; 2010.CrossRefGoogle Scholar
  2. 2.
    Mosby’s Dictionary of Medicine, Nursing & Health Professions. St. Louis: Mosby; 2009.Google Scholar
  3. 3.
    Travell J, Simons D. Travell & Simons’ myofascial pain and dysfunction: the trigger point manual. Philadelphia: Lippincott Williams & Wilkins; 1992.Google Scholar
  4. 4.
    Skootsky SA, Jaeger B, Oye RK. Prevalence of myofascial pain in general internal medicine practice. West J Med. 1989;151(2):157–60.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Portenoy RK, Kanner RM. Pain management: theory and practice. Philadelphia: F. A. Davis; 1996.Google Scholar
  6. 6.
    Gerwin RD. Classification, epidemiology, and natural history of myofascial pain syndrome. Curr Pain Headache Rep. 2001;5(5):412–20.CrossRefGoogle Scholar
  7. 7.
    Shah JP, Phillips TM, Danoff JV, Gerber LH. An in vivo microanalytical technique for measuring the local biochemical milieu of human skeletal muscle. J Appl Physiol. 2005;99(5):1977–84.CrossRefGoogle Scholar
  8. 8.
    Hubbard DR, Berkoff GM. Myofascial trigger points show spontaneous needle EMG activity. Spine. 1993;18(13):1803–7.CrossRefGoogle Scholar
  9. 9.
    Hubbard DR. Chronic and recurrent muscle pain. J Musculoskel Pain. 1996;4(1–2):123–44.CrossRefGoogle Scholar
  10. 10.
    Vecchiet L, Vecchiet J, Giamberardino MA. Referred muscle pain: clinical and pathophysiologic aspects. Curr Rev Pain. 1999;3(6):489–98.CrossRefGoogle Scholar
  11. 11.
    Bogduk N, Simons DG. Neck pain: joint pain or trigger points. In: Vaeroy H, Merskey H, editors. Progress in fibromyalgia and myofascial pain. Pain research and clinical management. Amsterdam: Elsevier; 1993.Google Scholar
  12. 12.
    Mense S, Gerwin R. Muscle pain: diagnosis and treatment. New York: Springer; 2010.CrossRefGoogle Scholar
  13. 13.
    Myburgh C, Larsen AH, Hartvigsen J. A systematic, critical review of manual palpation for identifying myofascial trigger points: evidence and clinical significance. Arch Phys Med Rehabil. 2008;89(6):1169–76.CrossRefGoogle Scholar
  14. 14.
    Gerwin RD, Shannon S, Hong CZ, Hubbard D, Gevirtz R. Interrater reliability in myofascial trigger point examination. Pain. 1997;69(1–2):65–73.CrossRefGoogle Scholar
  15. 15.
    Hong CZ, Kuan TS, Chen JT, Chen SM. Referred pain elicited by palpation and by needling of myofascial trigger points: a comparison. Arch Phys Med Rehabil. 1997;78(9):957–60.CrossRefGoogle Scholar
  16. 16.
    Ojala TA, Arokoski JPA, Partanen JV. Needle-electromyography findings of trigger points in neck-shoulder area before and after injection treatment. J Musculoskel Pain. 2006;14(1):5–14.CrossRefGoogle Scholar
  17. 17.
    Simons DG, Hong C-Z, Simons LS. Prevalence of spontaneous electrical activity at trigger spots and at control sites in rabbit skeletal muscle. J Musculoskel Pain. 1995;3(1):35–48.CrossRefGoogle Scholar
  18. 18.
    Sikdar S, Shah JP, Gilliams E, Gebreab T, Gerber LH, editors. Assessment of myofascial trigger points (MTrPs): a new application of ultrasound imaging and vibration sonoelastography. 30th Annual International IEEE EMBS Conference; Vancouver, BC, Canada; 2008.Google Scholar
  19. 19.
    Chen Q, Bensamoun S, Basford JR, Thompson JM, An KN. Identification and quantification of myofascial taut bands with magnetic resonance elastography. Arch Phys Med Rehabil. 2007;88(12):1658–61.CrossRefGoogle Scholar
  20. 20.
    Dibai-Filho AV, Guirro RR. Evaluation of myofascial trigger points using infrared thermography: a critical review of the literature. J Manipulative Physiol Ther. 2015;38(1):86–92.CrossRefGoogle Scholar
  21. 21.
    Hong CZ. Treatment of myofascial pain syndrome. Curr Pain Headache Rep. 2006;10(5):345–9.CrossRefGoogle Scholar
  22. 22.
    Bandura A. Self-efficacy mechanism in physiological activation and health-promoting behavior. In: Madden JL, Matthysse S, Barchas S, editors. Adaption, learning, and affect. New York: Raven Press; 1986.Google Scholar
  23. 23.
    Wu WT, Hong CZ, Chou LW. The Kinesio Taping method for myofascial pain control. Evid Based Complement Alternat Med. 2015;2015:950519.PubMedPubMedCentralGoogle Scholar
  24. 24.
    Desai MJ, Saini V, Saini S. Myofascial pain syndrome: a treatment review. Pain Ther. 2013;2(1):21–36.CrossRefGoogle Scholar
  25. 25.
    Cagnie B, Castelein B, Pollie F, Steelant L, Verhoeyen H, Cools A. Evidence for the use of ischemic compression and dry needling in the management of trigger points of the opper trapezius in patients with neck pain: a systematic review. Am J Phys Med Rehabil. 2015;94(7):573–83.CrossRefGoogle Scholar
  26. 26.
    Quinn SL, Olivier B, Wood WA. The short-term effects of trigger point therapy, stretching and medicine ball exercises on accuracy and back swing hip turn in elite, male golfers – a randomised controlled trial. Phys Ther Sport. 2016;22:16–22.CrossRefGoogle Scholar
  27. 27.
    Ajimsha MS, Al-Mudahka NR, Al-Madzhar JA. Effectiveness of myofascial release: systematic review of randomized controlled trials. J Bodyw Mov Ther. 2015;19(1):102–12.CrossRefGoogle Scholar
  28. 28.
    Menard MB. Immediate effect of therapeutic massage on pain sensation and unpleasantness: a consecutive case series. Glob Adv Health Med. 2015;4(5):56–60.CrossRefGoogle Scholar
  29. 29.
    Rai S, Ranjan V, Misra D, Panjwani S. Management of myofascial pain by therapeutic ultrasound and transcutaneous electrical nerve stimulation: a comparative study. Eur J Dent. 2016;10(1):46–53.CrossRefGoogle Scholar
  30. 30.
    Kaya A, Kamanli A, Ardicoglu O, Ozgocmen S, Ozkurt-Zengin F, Bayik Y. Direct current therapy with/without lidocaine iontophoresis in myofascial pain syndrome. Bratisl Lek Listy. 2009;110(3):185–91.PubMedGoogle Scholar
  31. 31.
    Srbely JZ, Dickey JP. Randomized controlled study of the antinociceptive effect of ultrasound on trigger point sensitivity: novel applications in myofascial therapy? Clin Rehabil. 2007;21(5):411–7.CrossRefGoogle Scholar
  32. 32.
    Kavadar G, Caglar N, Ozen S, Tutun S, Demircioglu D. Efficacy of conventional ultrasound therapy on myofascial pain syndrome: a placebo controlled study. Agri. 2015;27(4):190–6.PubMedGoogle Scholar
  33. 33.
    Carrasco TG, Guerisoli LD, Guerisoli DM, Mazzetto MO. Evaluation of low intensity laser therapy in myofascial pain syndrome. Cranio. 2009;27(4):243–7.CrossRefGoogle Scholar
  34. 34.
    Snyder-Mackler L, Bork C, Bourbon B, Trumbore D. Effect of helium-neon laser on musculoskeletal trigger points. Phys Ther. 1986;66(7):1087–90.CrossRefGoogle Scholar
  35. 35.
    Kiralp MZ, Uzun G, Dincer O, Sen A, Yildiz S, Tekin L, et al. A novel treatment modality for myofascial pain syndrome: hyperbaric oxygen therapy. J Natl Med Assoc. 2009;101(1):77–80.CrossRefGoogle Scholar
  36. 36.
    Lacey PH, Dodd GD, Shannon DJ. A double blind, placebo controlled study of piroxicam in the management of acute musculoskeletal disorders. Eur J Rheumatol Inflamm. 1984;7(3):95–104.PubMedGoogle Scholar
  37. 37.
    Benyamin R, Trescot AM, Datta S, Buenaventura R, Adlaka R, Sehgal N, et al. Opioid complications and side effects. Pain Physician. 2008;11(2 Suppl):S105–20.PubMedGoogle Scholar
  38. 38.
    Hsieh LF, Hong CZ, Chern SH, Chen CC. Efficacy and side effects of diclofenac patch in treatment of patients with myofascial pain syndrome of the upper trapezius. J Pain Symptom Manage. 2010;39(1):116–25.CrossRefGoogle Scholar
  39. 39.
    Affaitati G, Fabrizio A, Savini A, Lerza R, Tafuri E, Costantini R, et al. A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: evaluation of pain and somatic pain thresholds. Clin Ther. 2009;31(4):705–20.CrossRefGoogle Scholar
  40. 40.
    Firmani M, Miralles R, Casassus R. Effect of lidocaine patches on upper trapezius EMG activity and pain intensity in patients with myofascial trigger points: a randomized clinical study. Acta Odontol Scand. 2015;73(3):210–8.CrossRefGoogle Scholar
  41. 41.
    Hong CZ. Lidocaine injection versus dry needling to myofascial trigger point. The importance of the local twitch response. Am J Phys Med Rehabil. 1994;73(4):256–63.CrossRefGoogle Scholar
  42. 42.
    Peng PW, Castano ED. Survey of chronic pain practice by anesthesiologists in Canada. Can J Anaesth. 2005;52(4):383–9.CrossRefGoogle Scholar
  43. 43.
    Kung YY, Chen FP, Chaung HL, Chou CT, Tsai YY, Hwang SJ. Evaluation of acupuncture effect to chronic myofascial pain syndrome in the cervical and upper back regions by the concept of Meridians. Acupunct Electrother Res. 2001;26(3):195–202.CrossRefGoogle Scholar
  44. 44.
    Ga H, Choi JH, Park CH, Yoon HJ. Acupuncture needling versus lidocaine injection of trigger points in myofascial pain syndrome in elderly patients – a randomised trial. Acupunct Med. 2007;25(4):130–6.CrossRefGoogle Scholar
  45. 45.
    Gunn CC. Neuropathic myofascial pain syndromes. In: Loeser JD, Butler SH, Chapman CR, Turk DC, editors. Bonica’s managment of pain. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2001.Google Scholar
  46. 46.
    Cagnie B, Dewitte V, Barbe T, Timmermans F, Delrue N, Meeus M. Physiologic effects of dry needling. Curr Pain Headache Rep. 2013;17(8):348.CrossRefGoogle Scholar
  47. 47.
    Chou LW, Hsieh YL, Kuan TS, Hong CZ. Needling therapy for myofascial pain: recommended technique with multiple rapid needle insertion. Biomedicine. 2014;4:13.CrossRefGoogle Scholar
  48. 48.
    Khalifeh M, Mehta K, Varguise N, Suarez-Durall P, Enciso R. Botulinum toxin type A for the treatment of head and neck chronic myofascial pain syndrome: a systematic review and meta-analysis. J Am Dent Assoc. 2016;147(12):959–73.e1.CrossRefGoogle Scholar
  49. 49.
    Hackett R, Kam PC. Botulinum toxin: pharmacology and clinical developments: a literature review. Med Chem. 2007;3(4):333–45.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Rene Przkora
    • 1
  • Pavel Balduyeu
    • 1
  • Andrea Trescot
    • 2
  1. 1.Department of AnesthesiologyCollege of Medicine, University of  FloridaGainesvilleUSA
  2. 2.Pain and Headache CenterEagle RiverUSA

Personalised recommendations